老化メカニズムのバイオマーカー
1Institute of Longevity with Clinic of Rehabilitation and Preventive Medicine - Petrovsky National Research Centre of Surgery, Moscow, Russia.
Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury
|December 12, 2025
まとめ
この研究は、老化メカニズムを評価し、長寿医学を導くための30以上のバイオマーカーのシステムを提示する。それは、個人の老化速度の評価と介入のための参照値と目標値を提供する。
科学分野:
- 老年学と長寿医学
- バイオマーカーの発見と検証
- 老化の分子および細胞生物学
背景:
- 老化は、複数の相互に関連するメカニズムによって駆動される複雑なプロセスです。
- 老化バイオマーカーに関する現在の知識は、実践的な臨床応用のために体系化が必要です。
- 長寿医学は、個別化された介入を通じて老化を遅らせ、健康寿命を延ばすことを目指しています。
研究 の 目的:
- 基本的な老化メカニズムのバイオマーカーに関する現在の知識を統合および体系化すること。
- 長寿医学で使用するためのこれらのバイオマーカーの参照値と目標値を確立すること。
- 個人の老化評価のための包括的なバイオマーカーパネルを開発すること。
主な方法:
- 14の主要な老化メカニズムに関する科学文献の体系的な分析。
- ゲノム不安定性、テロメア短縮、エピジェネティック変化などの確立されたおよび新興の老化の特徴の包含。
- 細胞老化、ミトコンドリア機能不全、細胞間コミュニケーションに関連するバイオマーカーに焦点を当てる。
主要な成果:
- 詳細な参照値と目標値を持つ30以上のバイオマーカーの包括的なシステムが開発されました。
- 主要なバイオマーカーとして、尿中8-OHdG、白血球テロメア長、N7-メチルグアニン、およびオートファジー(p62、Beclin-1)のマーカーが特定されました。
- その他の重要なバイオマーカーには、HOMA-IR、IGF-1、ミトコンドリアマーカー、老化関連β-ガラクトシダーゼ、炎症性サイトカイン、マイクロバイオームマーカー、概日バイオマーカーが含まれます。
結論:
- 開発されたバイオマーカーパネルは、個人の老化速度評価のための科学的に検証されたアプローチを提供します。
- このパネルは、加齢に伴う変化の修正をサポートし、個別化された長寿戦略を促進します。
- バイオマーカーの動態と治療効果の有効な解釈のために、定期的なモニタリング(3〜6ヶ月ごと)が推奨されます。
関連する概念動画
Aging
566
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
566
The Effect of Aging on Tissues
3.1K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
3.1K
Pharmacodynamics in Geriatric Patients: Effects of Age
175
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
175
Mitochondria
19.5K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
19.5K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
181
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
181
Bone Disorders
5.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K


